| Literature DB >> 26355324 |
Imane El Menchawy1, Asmaa El Hamdouchi1, Khalid El Kari1, Naima Saeid1, Fatima Ezzahra Zahrou1, Nada Benajiba1, Imane El Harchaoui1, Mohamed El Mzibri1, Noureddine El Haloui1, Hassan Aguenaou1.
Abstract
Iron deficiency constitutes a major public health problem in Morocco, mainly among women and children. The aim of our paper is to assess the efficacy of consumption of multiple micronutrients (MMN) fortified milk on iron status of Moroccan schoolchildren living in rural region. Children (N = 195), aged 7 to 9 y, were recruited from schools and divided into two groups: the nonfortified group (NFG) received daily a nonfortified Ultra-High-Temperature (UHT) milk and the fortified group received (FG) daily UHT milk fortified with multiple micronutrients including iron sulfate. Blood samples were collected at baseline (T0) and after 9 months (T9). Hemoglobin (Hb) was measured in situ by Hemocue device; ferritin and C Reactive Protein were assessed in serum using ELISA and nephelometry techniques, respectively. Results were considered significant when the p value was <0.05. At T9 FG showed a reduction of iron deficiency from 50.9% to 37.2% (p = 0.037). Despite the low prevalence of iron deficiency anemia (1.9%); more than 50% of children in our sample suffered from iron deficiency at baseline. The consumption of fortified milk reduced the prevalence of iron deficiency by 27% in schoolchildren living in high altitude rural region of Morocco. Clinical Trial Registration. Our study is registered in the Pan African Clinical Trial Registry with the identification number PACTR201410000896410.Entities:
Year: 2015 PMID: 26355324 PMCID: PMC4556876 DOI: 10.1155/2015/690954
Source DB: PubMed Journal: J Nutr Metab ISSN: 2090-0724
Composition of nonfortified and fortified milk.
| Nutritional composition | Nonfortified milk | Fortified milk | ||
|---|---|---|---|---|
| Amount/200 mL serving | % RDIa
| Amount/200 mL serving | % RDIa
| |
| Energy (Kcal) | 154.8 | — | 154.8 | — |
| Fat (%) | 5.8 | — | 5.8 | — |
| Protein (g) | 5.8 | — | 5.8 | — |
| Lipids (g) | 6 | — | 6 | — |
| Carbohydrates (g) | 19.44 | — | 19.44 | — |
| Calcium (mg) | 240 | 30 | 240 | 30 |
| Iron (mg) | <0.4 | <3 | 4.2 | 30 |
| Iodine ( | 20.8 | <14 | 45 | 30 |
| Vitamin D3 ( | <1 | <10 | 3 | 30 |
| Vitamin A ( | 54 | <7 | 240 | 30 |
RDI: recommended dietary intake.
aThe values were based on the guidelines of the European Council 2008/100/CE relative to nutritional food labeling.
Figure 1Participant Flowchart: +dropouts: participants who either refused to give blood or were absent on the day of samples withdrawal, changed school or were relocated during study, or were excluded due to severe anemia (Hb < 9 mg/dL). SES: Socioeconomic Status, Hb: Hemoglobin, and CRP: C Reactive Protein.
Baseline demographic, anthropometric, and socioeconomic characteristics of schoolchildren enrolled in the study.
| Total ( | NFG ( | FG ( |
| ||||
|---|---|---|---|---|---|---|---|
| General characteristics | |||||||
| Age (y) (mean ± SD) | 8.0 ± 0.7 | 8.0 ± 0.7 | 7.9 ± 0.8 | 0.371 | |||
| Baseline anthropometry | |||||||
| Height (cm) (mean ± SD) | 122.3 ± 6.1 | 121.9 ± 6.3 | 122.8 ± 5.6 | 0.352 | |||
| Weight (kg) (mean ± SD) | 23.2 ± 3.0 | 23.1 ± 3.0 | 23.2 ± 2.9 | 0.483 | |||
| BMI (kg/m2) (mean ± SD) | 15.4 ± 1.1 | 15.5 ± 1.0 | 15.4 ± 1.2 | 0.358 | |||
| Nutritional status | |||||||
| Stuntinga HAZ <−2 SD (%) | 8.4 | 6.8 | 10.3 | 0.219 | |||
| Thinnessa BAZ <−2 SD (%) | 2.1 | 0 | 5.1 | ||||
|
| |||||||
| % | 95% CI | % | 95% CI | % | 95% CI |
| |
|
| |||||||
| Sex | |||||||
| Female | 50.6 | (42.9–58.3) | 52.4 | (42.7–61.2) | 47.7 | (35.4–60.0) | 0.815 |
| Male | 49.4 | (41.7–57.1) | 47.6 | (38.8–57.3) | 52.3 | (40.0–64.6) | |
| Level of education | |||||||
| Mother | |||||||
| Illiterate | 95.2 | (91.7–98.2) | 98.1 | (95.1–100.0) | 90.8 | (83.1–96.9) | 0.069 |
| Primary | 3.6 | (1.2–6.5) | 1.0 | (0.0–2.9) | 7.7 | (1.5–15.4) | |
| Secondary | 1.2 | (0.0–3.6) | 1.0 | (0.0–2.9) | 1.5 | (0.0–4.6) | |
| Father | |||||||
| Illiterate | 60.7 | (53.6–68.5) | 60.2 | (51.5–68.9) | 61.5 | (49.2–73.8) | 0.562 |
| Primary | 31.5 | (24.4–38.7) | 32.0 | (23.3–40.8) | 30.8 | (18.5–43.1) | |
| Secondary | 7.1 | (3.6–11.3) | 7.8 | (2.9–13.6) | 6.2 | (1.5–12.3) | |
| College | 0.6 | (0.0–1.8) | 0.0 | 1.5 | (0.0–4.6) | ||
| Household size | |||||||
| <6 persons | 48.8 | (41.1–56.5) | 49.5 | (39.8–59.2) | 47.7 | (35.4–60.0) | 0.944 |
| 6 to 10 persons | 51.2 | (43.5–58.9) | 50.5 | (40.8–60.2) | 52.3 | (40.0–64.6) | |
| Total monthly expense | |||||||
| <122US$ | 25.6 | (19.6–32.7) | 28.2 | (19.4–37.8) | 21.5 | (12.3–32.3) | 0.117 |
| 122–195US$ | 28.6 | (21.4–35.7) | 21.4 | (14.6–29.1) | 40.0 | (27.7–52.3) | |
| 196–244US$ | 26.2 | (20.2–32.7) | 31.1 | (22.3–39.8) | 18.5 | (9.2–29.2) | |
| 245–366US$ | 11.9 | (7.1–16.7) | 11.7 | (5.8–18.4) | 12.3 | (4.6–20.0) | |
| >367US$ | 7.7 | (4.2–11.9) | 7.8 | (2.9–13.6) | 7.7 | (1.5–13.8) | |
| Monthly expense for food | |||||||
| <110US$ | 63.1 | (55.4–70.2) | 60.2 | (50.5–69.9) | 67.7 | (55.4–78.5) | 0.076 |
| 110–147US$ | 18.5 | (12.5–24.4) | 23.3 | (15.5–31.1) | 10.8 | (3.1–18.5) | |
| 148–195US$ | 9.5 | (5.4–14.3) | 6.8 | (2.9–12.6) | 13.8 | (6.2–23.0) | |
| 196–305US$ | 8.3 | (4.8–12.5) | 9.7 | (3.9–16.5) | 6.2 | (1.5–12.3) | |
| >306US$ | 0.6 | (0.0–1.8) | 0.0 | 1.5 | (0.0–4.6) | ||
BMI: Body Mass Index; aHAZ and BAZ were calculated by Anthropo+.
Iron status at baseline and endpoint in the study groups.
| Biochemical parameters | Total | NFG | FG |
| |||
|---|---|---|---|---|---|---|---|
|
| Mean ± SD |
| Mean ± SD |
| Mean ± SD | ||
| Hemoglobin (mg/dL) | |||||||
| Baseline | 178 | 14.45 ± 1.46 | 114 | 14.58 ± 1.58 | 64 | 14.22 ± 1.21 | 0.090 |
| End line | 178 | 14.88 ± 1.35 | 114 | 15.05 ± 1.43 | 64 | 14.59 ± 1.16 | 0.213 |
|
| |||||||
|
| Median; interquartile |
| Median; interquartile |
| Median; interquartile |
| |
|
| |||||||
| Serum ferritin ( | |||||||
| Baseline | 158 | 13.0 (9.0; 21.0) | 101 | 13.0 (8.0; 21.0) | 57 | 14.0 (9.0; 20.0) | 0.610 |
| End line | 144 | 14.0 (9.0; 22.7) | 101 | 13.0 (8.0; 20.0) | 43 | 17.0 (11.0; 26.0) | 0.019 |
p value by one way ANOVA for means and Mann-Whitney test for medians.
Prevalence of anemia, iron deficiency anemia, and iron deficiency at baseline and endpoint in both groups.
| Total | NFG | FG | |||||
|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI |
| |
|
|
|
| |||||
| Anemiaa (Hb < 11.5 mg/dL) | |||||||
| Baseline | 2.2 | (0.6–4.5) | 2.6 | (0.0–6.1) | 1.6 | (0.0–4.7) | 0.999 |
| End line | 2.2 | (0.6–4.5) | 2.6 | (0.0–6.1) | 1.6 | (0.0–4.7) | 0.999 |
| Iron deficiency anemiab (Hb < 11.5 mg/dL and fe < 15 | |||||||
| Baseline | 1.9 | (0.0–4.5) | 2.0 | (0.0–5.0) | 1.8 | (0.0–5.3) | 0.760 |
| End line | 1.4 | (0.0–3.5) | 2.0 | (0.0–5.0) | 0.0 | (0.0–0.0) | 0.064 |
| Iron deficiencyc (Fe < 15 | |||||||
| Baseline |
|
|
| ||||
| 54.1 | (45.9–62.4) | 56.0 | (47.0–65.0) | 50.9 | (38.6–63.2) | 0.536 | |
| End line |
|
|
| ||||
| 50.7 | (43.1–59.0) | 56.4 | (45.6–66.3) | 37.2 | (23.3–51.2) | 0.035 | |
|
| 0.927 | 0.037 | |||||
p value for comparing deficiency prevalence among study groups using χ 2-test.
p value for comparing deficiency prevalence within same study group using Wilcoxon test.
aAnemia was defined as Hb levels <11.5 mg/dL. bIron deficiency anemia was defined as iron deficiency along with anemia by the above-mentioned criteria. cIron deficiency was defined as serum ferritin <15 μg/L.